Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-24

Clinical Trial Update: Clinical Characterization of Patients With Primary Biliary Cirrhosis Treated With Seladelpar in the Real-life Setting

View source ↗

Summary

This clinical trial update describes the real-world characterization of patients with primary biliary cholangitis treated with seladelpar, with the study curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Seladelpar (seladelpar)

Snippet

Sponsor: University of Leipzig | Conditions: Primary Bilary Cirrhosis (PBC) | Status: NOT_YET_RECRUITING